1Gould SF, Lopez RL, Speers WC. Malignant struma ovarii. A case report and literature review[ J]. J Reprod Med, 1983, 28 (6) :415 -419.
2Scully RE. Recent progress in varian cancer [J]. Hum Pathol, 2000, 1(1):73-98.
3Dardik RB, Dardik M, Westra W, et al. Malignant stmma ovarii: two case reports and a review of the literature [ J ]. Gynecol Oncol, 1999,73 (3) :447 - 451.
4Rotman- Pikielny P, Reynolds JC, Barker WC, et al. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii [ J ]. J Clin Endocrinol Metab, 2000, 85 ( 1 ) :237 - 244.
8Richard F, Paul S, Paul C, et al. BRAF T1799A mutation occurring in a case of malignant struma ovarii [ J ]. Inter J Surg Pathol, 2007, 15(2): 116-120.
9Vadmal MS, Smilari TF, Lovecchio JL, et al. Diagnosis and treatment of disseminated struma ovarii with malignant transformation [ J ]. Gynecol Oncol, 1997, 64 ( 3 ) :541 - 546.
10Rifka CS. A case of metastatic struma ovarii: the importance of close follow-up[ J]. Atara BSE, 2011, 32:43 - 49.
7Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control, 2008,19:585-593.
8Ahekruse SF, Kosary CL, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer, cancer, gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
9Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 2006,295:2164-2167.
10Pacini F, Castagna MG, Brilli L, et al. Difterentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol, 2008,19 ( Suppl 2 ) : ii99-ii101.
